GAS vaccination human trials in the 1960s, using a crude extract of M protein from type 3 GAS, resulted in devastating side effects in the volunteers, 12.5% of whom developed ARF (3 out of 21 volunteers) [80]. This evidence concerns the gene MYOM2 and rheumatic fever.